Dow Up 0.51% Nasdaq Up 0.24%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
28.43 Up 0.69(2.49%) Nov 21, 4:00PM EST
|After Hours : 28.55 Up 0.12 (0.42%) Nov 21, 6:46PM EST
Prev Close:27.74
Open:28.77
Bid:N/A
Ask:29.05 x 200
1y Target Est:38.17
Beta:3.12
Next Earnings Date:N/A
Day's Range:28.23 - 29.55
52wk Range:15.64 - 32.00
Volume:2,205,700
Avg Vol (3m):1,256,780
Market Cap:2.84B
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACADUp 2.49%2.84B
AZNUp 0.47%94.17B
LLYUp 0.84%72.05B
PFEUp 0.03%191.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25,391.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.91
Quarterly EPS Est (Dec-14) :-0.26
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback